← ANALYST RATINGS · TIPRANKS
Pulse Biosciences (PLSE): analyst forecast and price target
Analyst consensus
Strong Buy4 Buy0 Hold0 Sell
Ratings of 4 analysts in the last 3 months · top analysts only12-month forecast
Based on 4 price targets given in the last 3 months, the average target is $57.75, the highest $60.00, the lowest $55.00. The average is +30.0% from the last price of $44.43.
Analyst ratings 10
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $52.00 → $51.00−1.9% | Hold | +14.8% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $51.00 → $49.00−3.9% | Hold | +10.3% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $50.00 → $49.00−2.0% | Hold | +10.3% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $51.00 → $50.00−2.0% | Hold | +12.5% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $53.00 → $52.00−1.9% | Hold | +17.0% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $50.00 → $48.00−4.0% | Hold | +8.0% | Reiterated | 14.10.26on TipRanks 16:05 | — | |
| Suraj Kalia★★★★★★★★★★#1646 · hits 50% · avg +6.8% | Oppenheimer | $35.00 → $60.00+71.4% | Buy | +35.0% | Reiterated | 13.10.26on TipRanks 07:50 | −7.4%next day −3.5% | ↗ |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $45.00 → $55.00+22.2% | Buy | +23.8% | Assigned | 13.10.26on TipRanks 07:35 | −7.4%next day −3.5% | ↗ |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $49.00 → $51.00+4.1% | Hold | +14.8% | Reiterated | 07.10.26on TipRanks 11:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $51.00 → $50.00−2.0% | Hold | +12.5% | Reiterated | 07.10.26on TipRanks 11:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $50.00 → $51.00+2.0% | Hold | +14.8% | Reiterated | 07.10.26on TipRanks 11:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $54.00 → $53.00−1.9% | Hold | +19.3% | Reiterated | 07.10.26on TipRanks 11:05 | — | |
| Marie Thibault★★★★★★★★★★#12343 · hits 40% · avg −9.7% | BTIG | $70.00 | Buy | +57.6% | Reiterated | 06.10.26on TipRanks Oct 7 06:08 | −2.0%next day −1.1% · 5 days −2.3% | ↗ |
| William Plovanic★★★★★★★★★★#5377 · hits 43% · avg +1.3% | Canaccord Genuity | $58.00 | Buy | +30.5% | Reiterated | 06.10.26on TipRanks 06:50 | −2.0%next day −1.1% · 5 days −2.3% | ↗ |
| Marie Thibault★★★★★★★★★★#12343 · hits 40% · avg −9.7% | BTIG | $70.00 | Buy | +57.6% | Initiated | 23.09.26on TipRanks 05:45 | −0.6%next day −0.2% · 5 days −3.3% | ↗ |
| AI xAi Medical - Instruments and SuppliesxAI Grok-3 | TipRanks - xAI | $59.00 → $52.00−11.9% | Hold | +17.0% | Reiterated | 17.09.26on TipRanks 07:05 | — | |
| AI DeepSeek Medical - Instruments and SuppliesDeepSeek V3.2-Speciale | TipRanks - DeepSeek | $56.00 → $49.00−12.5% | Hold | +10.3% | Reiterated | 17.09.26on TipRanks 07:05 | — | |
| AI OpenAI Medical - Instruments and SuppliesOpenAI 5.2 | TipRanks - OpenAI | $57.00 → $51.00−10.5% | Hold | +14.8% | Reiterated | 17.09.26on TipRanks 07:05 | — | |
| AI Anthropic Medical - Instruments and SuppliesAnthropic Opus-4.5 | TipRanks - Anthropic | $56.00 → $50.00−10.7% | Hold | +12.5% | Reiterated | 17.09.26on TipRanks 07:05 | — | |
| AI Google Medical - Instruments and SuppliesGemini 3-pro | TipRanks - Google | $58.00 → $54.00−6.9% | Hold | +21.5% | Reiterated | 17.09.26on TipRanks 07:05 | — | |
| AI PerPlexity Medical - Instruments and SuppliesPerPlexity SonarPro | TipRanks - PerPlexity | $57.00 → $50.00−12.3% | Hold | +12.5% | Reiterated | 17.09.26on TipRanks 07:05 | — | |
| Keith Hinton★★★★★★★★★★#7123 · hits 80% · avg +7.0% | Freedom Capital Markets | $73.00 | Buy | +64.3% | Initiated | 09.09.26on TipRanks 06:30 | +9.0%next day +3.4% · 5 days −5.2% | ↗ |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | $12.56 → $58.00+361.8% | Buy | +30.5% | Initiated | 17.08.26on TipRanks 06:51 | +5.5%next day −1.0% · 5 days +6.2% | ↗ |
| William Plovanic★★★★★★★★★★#5377 · hits 43% · avg +1.3% | Canaccord Genuity | $43.00 | Buy | −3.2% | Reiterated | 11.08.26on TipRanks Aug 10 07:25 | −2.1%next day +7.3% · 5 days +12.8% | ↗ |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $30.00 → $45.00+50.0% | Buy | +1.3% | Reiterated | 10.08.26on TipRanks 07:25 | −2.1%next day +7.3% · 5 days +12.8% | ↗ |
| Suraj Kalia★★★★★★★★★★#1646 · hits 50% · avg +6.8% | Oppenheimer | $30.00 → $35.00+16.7% | Buy | −21.2% | Reiterated | 28.07.26on TipRanks 07:40 | +7.9%next day −1.9% · 5 days +3.5% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Pulse Biosciences
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $54.00 at a price of $49.92 (+8.2%); now: $62.33 at $44.43 (+40.3%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 1 | 3 | 6 | 5 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 16.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.31 (from $-0.36 to $-0.28). Last quarter: $-0.28.
Sales
Next quarter’s sales estimate — $1M (from $0M to $1M). Last quarter: $0M.
Best top-analyst consensus in the sector · Healthcare
About Pulse Biosciences
- CEO: Paul Arthur LaViolette
- Employees: 116
- 601 Brickell Key Drive, Miami, FL, 33131, US
- www.pulsebiosciences.com
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Data from the stock’s TipRanks forecast page, read 2 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗